Titlebook: Carcinogenicity; The Design, Analysis Harold C. Grice,Joseph L. Ciminera Book 1988Latest edition Springer-Verlag New York Inc. 1988 cancer.

FELON

https://doi.org/10.1007/978-1-4684-1788-3 adverse effect. These studies are conducted in laboratory animals. One of the key elements in interpretation of these studies is the histopathologic evaluation of tissues from the test animals. From this evaluation, the incidences of various lesions observed can be compared between treated and cont

Cytokines

ESO

Akio Matsumoto,Ferenc Szidarovszkyeral issues related to dose selection, including number and spacing of doses and selection of the highest dose, were mentioned during the formal presentations, the informal discussion centered primarily on the selection of the highest dose level.

Factorable

Foolproof

拔出

Statistical Tests with Historical Controlsoups evaluated relative to those in unexposed controls (Bickis and Krewski, 1985a). The untreated animals are maintained on test at the same time as the treated animals and housed under the same conditions in the same laboratory. Because the concurrent controls are thus similar to the exposed animal

ALLAY

The Value of Historical Control Datanmental chemicals or pharmaceutical agents. Such studies are generally performed in both sexes of two rodent species, typically rats and mice, over a period of about 24 months. Chronic toxicity studies are also carried out in larger laboratory animal species, such as monkeys or dogs. The duration of

FLAIL

最后一個(gè)

Integration of Pharmacokinetics and Pathological Data in Dose Selection for Chronic Bioassays of pharmacokinetics to the design and interpretation of toxicology studies is the concept of dose-dependent or nonlinear kinetics. Many of the physiological and biochemical processes that affect the disposition of chemicals in the body are capacity limited (i.e., saturable). When any of the rate-li

錯(cuò)事